BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19111929)

  • 1. Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.
    Dong X; Mattingly CA; Tseng M; Cho M; Adams VR; Mumper RJ
    Eur J Pharm Biopharm; 2009 May; 72(1):9-17. PubMed ID: 19111929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor.
    Chen L; Chen B; Deng L; Gao B; Zhang Y; Wu C; Yu N; Zhou Q; Yao J; Chen J
    Int J Pharm; 2017 Dec; 534(1-2):308-315. PubMed ID: 28986321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo.
    Feng L; Wu H; Ma P; Mumper RJ; Benhabbour SR
    Int J Nanomedicine; 2011; 6():2545-56. PubMed ID: 22072889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
    Pan J; Feng SS
    Biomaterials; 2008 Jun; 29(17):2663-72. PubMed ID: 18396333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
    Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
    Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
    Mu L; Feng SS
    J Control Release; 2003 Jan; 86(1):33-48. PubMed ID: 12490371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
    Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
    Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.
    Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J
    Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
    Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
    J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in-vitro characterization of nanoemulsions loaded with paclitaxel/γ-tocotrienol lipid conjugates.
    Abu-Fayyad A; Kamal MM; Carroll JL; Dragoi AM; Cody R; Cardelli J; Nazzal S
    Int J Pharm; 2018 Jan; 536(1):146-157. PubMed ID: 29195915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy.
    Zhang Z; Lee SH; Gan CW; Feng SS
    Pharm Res; 2008 Aug; 25(8):1925-35. PubMed ID: 18509603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
    Lv W; Cheng L; Li B
    Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
    Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network.
    Fan T; Takayama K; Hattori Y; Maitani Y
    Pharm Res; 2004 Sep; 21(9):1692-7. PubMed ID: 15497698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors.
    Hsu CH; Cui Z; Mumper RJ; Jay M
    AAPS PharmSciTech; 2003; 4(3):E32. PubMed ID: 14621964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines.
    Najlah M; Kadam A; Wan KW; Ahmed W; Taylor KM; Elhissi AM
    Int J Pharm; 2016 Jun; 506(1-2):102-9. PubMed ID: 27107899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel nanoparticles for the potential treatment of brain tumors.
    Koziara JM; Lockman PR; Allen DD; Mumper RJ
    J Control Release; 2004 Sep; 99(2):259-69. PubMed ID: 15380635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.